Zandu Realty (Delisted) financials and balance sheet

BSE: 506720

Formerly Zandu Pharmaceutical works

Last traded ₹1,902.05 on 23 May 2018

Delisted on 18 Mar 2019.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Zandu Realty annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
A loss in 1 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

The years either side of a change of basis do not compare. From the year to Mar 2009, the company's revenue for that year, ₹88 Cr, differs from its quarters added, ₹165 Cr.

Results for the year to Mar 2017

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue5.1
  2. Other income+12
  3. Finance costs−1.4
  4. Profit before tax6.5
  5. Tax−1.4
  6. Net profit5.2

Profit and loss

Standalone, ₹ crore, years to March.Zandu Realty quarterly results

₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Revenue from operations13788––70–298795
––––––––––
Materials and goods bought3−1––––––––
Other income46215627871512
Finance costs00––––0221
Profit before tax242111−672508297
Tax860031111721
Net profit161511−701386475
Net margin12.0%17.4%––−100.4%–132.3%74.0%81.3%101.0%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2008, Mar 2009, Mar 2014, Mar 2015, Mar 2016 and Mar 2017: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2010, Mar 2011 and Mar 2013: the statement does not state its revenue, finance costs or depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2012: the statement does not state its finance costs or depreciation, which operating profit is worked out from, so operating profit is not given.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Earnings per share−₹871.55₹16.72₹476.60––₹64.20
Diluted earnings per share−₹871.55₹16.72₹476.60––₹64.20
Market cap at the year end (₹ crore)1298972139––

Ratios

Standalone, years to March.

RatioMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Revenue growth–––––199.3%−90.0%−40.9%
Net profit growth−90.9%−34.3%––2,751.0%67.2%−89.0%−26.5%
Earnings per share growth––––2,750.5%–––
Revenue growth and net profit growth are left blank for the year to Mar 2009: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2017.

Measure5 years3 years
Revenue growth, yearly rate−40.7%−43.9%
Profit growth, yearly rate–−48.7%
Net margin, average97.2%85.4%

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Effective tax ratePublished threshold 17.16 per cent27.74−5.46−12.56–36.2622.4421.2120.1020.78
A threshold marked as ours has no published figure; it is the line we read the check against.